Trustmark (TRMK) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The 2025 annual meeting will be held virtually on April 22, 2025, with shareholders voting on director elections, executive compensation, and auditor ratification.
2024 was a transformational year, highlighted by the sale of the insurance agency, balance sheet restructuring, and expanded sales and service initiatives, resulting in improved capital levels and increased dividends and share repurchases.
Adjusted net income from continuing operations in 2024 was $186.3 million, up 17% from 2023, with diluted EPS rising to $3.04.
Voting matters and shareholder proposals
Shareholders will vote on electing 11 directors, an advisory say-on-pay for executive compensation, and ratification of Crowe LLP as independent auditor.
Shareholder proposals and director nominations for the 2026 meeting must follow specific bylaw procedures and deadlines.
Board of directors and corporate governance
Nine of eleven board members are independent; directors must meet stock ownership and retirement requirements.
The board has formal charters, codes of conduct, and a CEO succession plan; independent directors meet without management.
Board committees include Audit, Enterprise Risk, Executive, Finance, Human Resources, and Nominating & Governance, all with defined responsibilities.
Board diversity is tracked, with a mix of gender and ethnic backgrounds.
Latest events from Trustmark
- Record earnings, dividend increase, and strong ESG initiatives mark a year of growth and engagement.TRMK
Proxy Filing16 Mar 2026 - Key votes include director elections, executive pay approval, and auditor ratification for 2026.TRMK
Proxy Filing16 Mar 2026 - Record earnings, robust governance, and strong ESG drive 2026 proxy voting recommendations.TRMK
Proxy Filing16 Mar 2026 - Record earnings, higher dividend, and strong capital ratios highlight robust 2025 performance.TRMK
Q4 20253 Feb 2026 - Q2 net income surged on FBBI sale, despite a $182.8M securities loss, with stronger capital.TRMK
Q2 20243 Feb 2026 - Q3 2024 net income rose 51% year-over-year, with higher margins and improved capital ratios.TRMK
Q3 202419 Jan 2026 - Q4 net income up 9.7%, capital and EPS rise on asset sales, with a strong 2025 outlook.TRMK
Q4 20249 Jan 2026 - Q1 2025 net income reached $53.6M, with strong loan growth and stable credit quality.TRMK
Q1 202525 Dec 2025 - Virtual meeting to elect directors, approve pay, and ratify auditor, all board-backed.TRMK
Proxy Filing1 Dec 2025